AngioDynamics Announces Trial Date of March 12, 2007 in Diomed Patent Litigation QUEENSBURY, N.Y.--(BUSINESS WIRE)--Dec. 8, 2006--AngioDynamics, Inc. (Nasdaq:ANGO) today announced that U.S. District Judge Nathaniel M. Gorton has set March 12, 2007 as the start date for the jury trial in the Diomed

RITA Medical CEO to Present at the RBC Capital Markets 2006 Healthcare Conference FREMONT, Calif., Dec 07, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- RITA Medical Systems, Inc. (Nasdaq: RITA), a publicly-traded medical device company focused solely on cancer therapies, today announced

AngioDynamics to Present at RBC Capital Markets 2006 Healthcare Conference QUEENSBURY, N.Y.--(BUSINESS WIRE)--Dec. 6, 2006--AngioDynamics, Inc. (Nasdaq:ANGO) today announced that its president and chief executive officer, Eamonn P. Hobbs, will participate in a panel entitled: "Away From the Heart:

Newly Introduced Laparoscopic Surgical Device Designed to Reduce Blood Loss, Decrease Operating Times, Coagulate Highly Vascularized Tissue

Complementary Products and Shared Customer Bases Provide Clear Strategic Fit

Expected to Result in Approximately $0.05 EPS Accretion in Fiscal Year 2008

Conference Call Begins Today at 11:30 a.m. Eastern Time

AngioDynamics Announces FDA Clearance for Irreversible Electroporation Technology QUEENSBURY, N.Y.--(BUSINESS WIRE)--Nov. 27, 2006--AngioDynamics, Inc. (Nasdaq:ANGO) announces that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Oncobionic, Inc.

AngioDynamics Comments on Markman Ruling in VNUS Litigation QUEENSBURY, N.Y.--(BUSINESS WIRE)--Nov. 21, 2006--AngioDynamics, Inc. (Nasdaq:ANGO) today announced that on November 20, 2006, United States District Court Judge Maxine Chesney issued a Markman ruling in the first stage of the patent

Company Achieves Record $12.9 Million Revenue

Achieved a 40% Sequential Reduction in the GAAP Net Loss

Generated Profitable Quarterly Results on a Non-GAAP Pro-Forma Basis

Achieved Positive Cash Flow From Operations for the Quarter and Year to Date

AngioDynamics to Present at Rodman & Renshaw Eighth Annual Healthcare Conference AngioDynamics to Present at Rodman & Renshaw Eighth Annual Healthcare Conference QUEENSBURY, N.Y.--(BUSINESS WIRE)--Oct. 31, 2006--AngioDynamics, Inc., (Nasdaq:ANGO) today announced that its president and chief

First Three Clinical Cases Using the Investigational Starburst Assure(TM) RF Electrode Performed

RITA Medical to Present at the C.E. Unterberg, Towbin Life Sciences Conference FREMONT, Calif., Oct. 25 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA), a publicly-traded medical device company focused solely on cancer therapies, today announced that it will present at the C.E.

AngioDynamics Named to Forbes 200 Best Small Companies List QUEENSBURY, N.Y., Oct 18, 2006 (BUSINESS WIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO) today announced that it was named to the list of the 200 Best Small Companies in America published in the October 30, 2006 issue of Forbes.

Company Expects to Begin Shipping Product in the Second Half of the Fourth Quarter of 2006

AngioDynamics to Acquire Oncobionic and Its Revolutionary New Cancer Therapy QUEENSBURY, N.Y.--(BUSINESS WIRE)--Oct. 17, 2006--AngioDynamics, Inc. (NASDAQ:ANGO) announces the signing of an agreement to acquire Oncobionic, Inc., a privately held company that has developed an irreversible

91% Reduction in Need for Re-Excision due to Inadequate Margins Reported in Presentation at 92nd Annual Clinical Congress of the American College of Surgeons

RITA Medical Systems Announces Third Quarter 2006 Earnings Release Date and Conference Call Fremont, Calif., Oct. 10 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) today announced that it will release financial results for the third quarter ended September 30, 2006, after the

AngioDynamics Names Robert Mitchell Chief Operating Officer QUEENSBURY, N.Y.--(BUSINESS WIRE)--Oct. 9, 2006--AngioDynamics, Inc. (Nasdaq: ANGO), a leading provider of medical devices for the minimally invasive diagnosis and treatment of peripheral vascular disease announced today that it has

- Early Radiofrequency Ablation Treatment Demonstrates Encouraging Impact
on Survival

- Chemoembolization Using Drug-Eluting Beads Shows Promise

- RITA RFA Devices Demonstrate Lower Local Tumor Recurrence Rate Versus
Competitors

Conference Call Begins Today at 4:30 P.M. Eastern Time

AngioDynamics to Present at UBS 2006 Global Life Sciences Investor Conference QUEENSBURY, N.Y.--(BUSINESS WIRE)--Sept. 20, 2006--AngioDynamics, Inc. (NASDAQ:ANGO) announced that Joseph G. Gerardi, AngioDynamics' chief financial officer, will present at the UBS 2006 Global Life Sciences Conference